1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1b study of once-weekly carfilzomib combined with lenalido-mide and dexamethasone (wKRd) in patients (pts) with newly diagnosed multiple myeloma (NDMM)
    Meeting Abstract

    Alsina, M.; Landgren, C. O.; Raje, N.; Niesvizky, R.; Bensinger, W. I.; Berdeja, J.; Kovacsovics, T.; Vesole, D.; Fang, B.; Kimball, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • A prospective study of circulating chemokines and angiogenesis markers and risk of multiple myeloma and its precursor
    Meeting Abstract

    Hofmann, J.; Landgren, C. O.; Landy, R.; Kemp, T.; Santo, L.; McShane, C.; Shearer, J.; Lan, Q.; Rothman, N.; Pinto, L.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Analysis of the genomic and transcriptomic landscape of chemoresistant multiple myeloma
    Meeting Abstract

    Ziccheddu, B.; Biancon, G.; Dugo, M.; Devecchi, A.; De Philippis, C.; Bagnoli, F.; Maura, F.; De Cecco, L.; Gimondi, S.; Vendramin, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Practice patterns with focal progression on daratumumab therapy
    Meeting Abstract

    Bal, S.; Peterson, T.; Landau, H.; Chung, D.; Giralt, S.; Korde, N.; Mailankody, S.; Smith, E.; Shah, U.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Fractures and survival in multiple myeloma: Results from a population-based study
    Meeting Abstract

    Thorsteinsdottir, S.; Gislason, G.; Aspelund, T.; Sverrisdottir, I.; Landgren, C. O.; Turesson, I.; Bjorkholm, M.; Kristinsson, S.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Dynamic monitoring of minimal residual disease reveals its superior prognostic significance in multiple myeloma
    Meeting Abstract

    Jin, F. Y.; Landgren, C. O.; Dai, Y.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Clinical and biological early relapse predictors in multiple myeloma: An analysis from the MMRF CoMMpass study
    Meeting Abstract

    D'Agostino, M.; Zaccaria, G. M.; Ziccheddu, B.; Genuardi, E.; Maura, F.; Oliva, S.; Auclair, D.; Yesil, J.; Capra, A.; Colucci, P.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Stem cell mobilization and autograft purity with novel induction regimens in multiple myeloma
    Meeting Abstract

    Bal, S.; Landau, H.; Shah, G.; Scordo, M.; Dahi, P.; Lahoud, O.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lesokhin, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Synthesis, preclinical analysis, and first-in-human phase I imaging of 89Zr-DFO-daratumumab for CD38 targeted imaging of myeloma
    Meeting Abstract

    Ulaner, G.; Sobol, N.; O'Donoghue, J.; Lyashchenko, S.; Lewis, J.; Landgren, C. O.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Timing the initiation of multiple myeloma
    Meeting Abstract

    Maura, F.; Rustad, E.; Yellapantula, V.; Bolli, N.; Leongamornlert, D.; Nadeu, F.; Angelopoulos, N.; Dawson, K.; Mitchell, T.; Osborne, R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save